title: Long-term stimulation of Toll-like receptor 3 in primary human hepatocytes leads to sensitization for antiviral responses induced by poly I:C treatment.
abstract: Chronic hepatitis C infection is associated with increased expression of interferon-sensitive genes (ISGs) in the liver, which is, paradoxically, correlated with the nonresponse to interferon (IFN)-based therapies. In the present study PHHs were isolated from HCV-infected or uninfected patients and stimulated with the TLR1-9 ligands for 6-24 h. Expression of cytokines and ISGs was determined by ELISA and qRT-PCR. A comparative analysis was performed for TLR3 signalling, which was also correlated with single nucleotide polymorphisms (SNPs) related to HCV pathogenesis. TLR-activated PHHs produced pro-inflammatory and anti-inflammatory cytokines, whereas IFNs were exclusively induced by TLR3 stimulation. Here, IL-29 and IL-28A were significantly highly expressed than IFN-α and IFN-β. TLR3-induced IFN response was enhanced in hepatocytes isolated from patients with HCV infection. This hyper-responsiveness could be mimicked in naïve PHHs consistently stimulated with low dose of poly I:C, but not Guardiquimod. The higher responsiveness in PHH isolated from HCV-infected patients could be partially explained by higher frequencies of unfavourable SNP alleles of different SNPs associated with HCV progression and treatment outcome. These data suggest that durable activation of TLR3 but not TLR7, by low doses of viral replicative intermediates, increases the sensitivity to viral invasion. These findings shed new light on the relevance of TLR3 in the pathogenesis of HCV and may provide a possible explanation for the increased ISG expression during chronic HCV infection, the so-called IFN paradox.
authors.affiliation: Department of Gastroenterology and Hepatology, University Hospital, University Duisburg-Essen, Essen, Germany.
authors.forename: R
authors.initials: R
authors.lastname: Broering
authors.forename: M
authors.initials: M
authors.lastname: Lutterbeck
authors.forename: M
authors.initials: M
authors.lastname: Trippler
authors.forename: K
authors.initials: K
authors.lastname: Kleinehr
authors.forename: L
authors.initials: L
authors.lastname: Poggenpohl
authors.forename: A
authors.initials: A
authors.lastname: Paul
authors.forename: G
authors.initials: G
authors.lastname: Gerken
authors.forename: J F
authors.initials: JF
authors.lastname: Schlaak
mesh_terms: D000276:Adjuvants, Immunologic / Q000494:pharmacology*; D016207:Cytokines / Q000378:metabolism; D004797:Enzyme-Linked Immunosorbent Assay; D020869:Gene Expression Profiling; D022781:Hepatocytes / Q000187:drug effects* / Q000276:immunology*; D006801:Humans; D011070:Poly I-C / Q000494:pharmacology*; D051196:Toll-Like Receptor 3 / Q000276:immunology*
chemical_list: D000276:Adjuvants, Immunologic; D016207:Cytokines; C495344:TLR3 protein, human; D051196:Toll-Like Receptor 3; D011070:Poly I-C
keywords: Toll-like receptors; hepatitis C virus; interleukin-28A/B; interleukin-29; primary human hepatocytes